Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nan Fung Life Sciences

Nan Fung Life Sciences
VC INVESTOR TYPE
Active STATUS
25 PROFESSIONALS
45 INVESTMENTS
32 PORTFOLIO
11 EXITS
Description

Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. Leveraging on Nan Fung Group's capital base and long-term commitment to the area, the company aims to become a partner for scientists, entrepreneurs, corporations and investors in the life science space. Through direct investments via Pivotal bioVenture Partners funds (both in US and China) and fund investments covering full spectrum of the industry (including therapeutics, medical devices and diagnostics) and across different development stages, Nan Fung Life Sciences has presence in both US and Greater China. The firm was founded in 2017 and is based in Hong Kong.

Investor Status
Actively Seeking New Investments
Year Founded
2017
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
PE/Buyout
Primary Office
  • 23rd Floor, Nan Fung Tower
  • 88 Connaught Road C, Central
  • Hong Kong
  • Hong Kong

Nan Fung Life Sciences Investments & Acquisitions (45)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Oncologie 10-Jun-2019 Early Stage VC 0000 Biotechnology Clinical Trials - Phase 2
0000000 000000 10-Apr-2019 00000 00000 0000 Biotechnology Startup
000000 00000000000 01-Apr-2019 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 0000000 0000000 00
000000 00000000000 25-Mar-2019 00000 00000 00000 Drug Discovery Clinical Trials - Phase 1 0000000 0000000 00
000000 00000000000 18-Feb-2019 00000 00000 00000 Biotechnology Startup
0000 0000000000000 05-Feb-2019 00000 00000 0000 Biotechnology Startup 000000 000000 00.0
00000 19-Dec-2018 00000 00000 000.00 Other Devices and Supplies Generating Revenue
00000000 07-Nov-2018 00000 00000 Other Consumer Products and Services Startup
Galera Therapeutics 30-Aug-2018 Later Stage VC 00000 Biotechnology Clinical Trials - Phase 3
Encodia 20-Jul-2018 Early Stage VC 000 Biotechnology Generating Revenue
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nan Fung Life Sciences’s full profile, request a free trial.

Nan Fung Life Sciences Exits (10)

Company Name Exit Date Exit Type Exit Size Status Buyers
Stealth BioTherapeutics 15-Feb-2019 IPO 0000 Completed
00000000 000 08-Feb-2019 000 00000 Completed
00000 0000000000 31-Oct-2018 000 0000 Completed
0000000 0000000000 26-Sep-2018 000 0000 Completed
0000000 21-Jun-2018 000 00000 Completed
000000 00000000000 25-May-2018 000 0000 Completed
0000 000000 08-May-2018 000 00000 Completed
00000 000000000000 03-May-2018 000 0000 Completed
Synlogic 28-Aug-2017 Reverse Merger Completed
Athenex 14-Jun-2017 IPO 0000 Completed
  • 2 buyers
To view this investor’s complete exits history, request access »

Nan Fung Life Sciences Team (13)

Name Title Deals Funds Boards Office Contact
Info
Vincent Cheung Managing Partner & Founder 0 0 0 San Francisco, CA
Heather Preston MD Managing Partner 00 0 0 San Francisco, CA
Peter Tuxen Bisgaard Managing Partner 00 0 0 San Francisco, CA
Robert Hopfner Ph.D Managing Partner 0 0 0 San Francisco, CA
Ashish Khanna Ph.D Venture Partner 0 0 0 San Francisco, CA

1 Former Team Member

You’re viewing 5 of 13 team members. Get the full list »